Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas

被引:41
作者
Michelland, S [1 ]
Gazzeri, S
Brambilla, E
Robert-Nicoud, M
机构
[1] Inst Albert Bonniot, INSERM, U309, Equipe DyOGen, F-38706 La Tronche, France
[2] Inst Albert Bonniot, INSERM, Grp Rech Canc Pouman, F-38706 La Tronche, France
关键词
D O I
10.1016/S0165-4608(99)00035-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung carcinomas are represented by non-small-cell lung carcinomas (NSCLC) and neuroendocrine carcinomas (NE) which differ in their clinical presentation and prognosis. We used comparative genomic hybridization (CGH) to characterize and compare the chromosomal pattern of 11 NSCLC and 11 high-grade NE lung carcinomas. Overall, the total number of aberrations was higher in NSCLC than in high-grade NE lung tumors (p < 0.05) and gains predominated over losses in NSCLC (p < 0.0003). Gains common to both lung tumor phenotypes were detected in 1p, 1q, 3q, 5p, 6p, 8q, 12, 17q, 19p, 19q, 20p, 20q, and X, whereas common losses were found in 2q, 3p, 4p, 4q, 5q, 8p, 9p, 10p, 11p 11q, 13q, and 17p. Major gains on 18q and losses on 2p and 16q were exclusively detected in high-grade NE lung tumors. On the other hand, major gains on 2p and 15q and losses on 21q were found only in NSCLC. Furthermore, gains within 22q11 similar to q12 and 7p12 similar to p15 were associated with NSCLC(p < 0.05). The differences in the pattern and distribution of genetic changes observed in NSCLC as opposed to high-grade NE lung carcinomas suggest the existence of distinct tumorigenic pathways between these toro major classes of lung tumors. (C) Elsevier Science Inc., 1999. All rights reserved.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 49 条
[1]  
Balsara BR, 1997, CANCER RES, V57, P2116
[2]   3 TUMOR-SUPPRESSOR REGIONS ON CHROMOSOME-11P IDENTIFIED BY HIGH-RESOLUTION DELETION MAPPING IN HUMAN NON-SMALL-CELL LUNG-CANCER [J].
BEPLER, G ;
GARCIABLANCO, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5513-5517
[3]   Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung [J].
Björkqvist, AM ;
Tammilehto, L ;
Nordling, S ;
Nurminen, M ;
Anttila, S ;
Mattson, K ;
Knuutila, S .
BRITISH JOURNAL OF CANCER, 1998, 77 (02) :260-269
[4]   BASAL-CELL (BASALOID) CARCINOMA OF THE LUNG - A NEW MORPHOLOGICAL AND PHENOTYPIC ENTITY WITH SEPARATE PROGNOSTIC-SIGNIFICANCE [J].
BRAMBILLA, E ;
MORO, D ;
VEALE, D ;
BRICHON, PY ;
STOEBNER, P ;
PARAMELLE, B ;
BRAMBILLA, C .
HUMAN PATHOLOGY, 1992, 23 (09) :993-1003
[5]  
Brambilla E, 1996, AM J PATHOL, V149, P1941
[6]  
CAGALE PT, 1997, AM J PATHOL, V150, P393
[7]   DETECTION OF COMPLETE AND PARTIAL CHROMOSOME GAINS AND LOSSES BY COMPARATIVE GENOMIC INSITU HYBRIDIZATION [J].
DUMANOIR, S ;
SPEICHER, MR ;
JOOS, S ;
SCHROCK, E ;
POPP, S ;
DOHNER, H ;
KOVACS, G ;
ROBERTNICOUD, M ;
LICHTER, P ;
CREMER, T .
HUMAN GENETICS, 1993, 90 (06) :590-610
[8]  
FONG KM, 1995, CANCER RES, V55, P220
[9]   Mechanisms of p16INK4A inactivation in non small-cell lung cancers [J].
Gazzeri, S ;
Gouyer, V ;
Vourc'h, C ;
Brambilla, C ;
Brambilla, E .
ONCOGENE, 1998, 16 (04) :497-504
[10]  
GAZZERI S, IN PRESS CANC RES